The Biology and Genetics of SHE

While Sleep-related hypermotor epilepsy (SHE) is a “focal” epilepsy—meaning the seizures start in one specific network in the brain—the reason they start can sometimes be traced back to your DNA. Understanding the biology and genetics of SHE helps explain why some people have “perfectly normal” brain scans while others have small structural differences that trigger their seizures ^[1][2].

The Core Mechanism: Focal Onset

In SHE, the brain’s “electrical storm” typically begins in the frontal lobe (the area behind the forehead) or, less commonly, in the temporal or parietal lobes ^[1][3]. During the transition between sleep stages, these areas can become hyperexcitable, leading to the sudden, vigorous movements characteristic of the condition ^[4][5].

Sporadic vs. Familial SHE

Most cases of SHE are sporadic (about 86% in cohort studies), meaning the person is the first in their family to have the condition, with no identified family history ^[6]. However, about 14% of cases are familial, occurring in families where multiple members are affected. This inherited form is called Autosomal Dominant Sleep-related Hypermotor Epilepsy (ADSHE) ^[6][7].

It is important to know that even if you carry a “seizure gene,” you might never actually have a seizure. This is called incomplete penetrance. For example, in families with ADSHE, studies estimate only about 70% of people who carry the gene will develop epilepsy ^[7][8]. Keep in mind that a lack of family history does not exclude a genetic cause (due to spontaneous de novo variants), and a negative genetic panel does not rule out all genetic contributions.

The Main Genetic Groups

Researchers have identified several key “players” in the genetics of SHE. These are often grouped by the job they do in the brain:

1. The “Gatekeepers” (Nicotinic Receptors)

The first genes ever linked to SHE were the nicotinic acetylcholine receptor genes (CHRNA4, CHRNB2, and CHRNA2) ^[9]. These genes help control the “gates” that allow electrical signals to move between brain cells ^[5]. When these gates don’t work correctly, the brain’s balance between “go” signals (excitation) and “stop” signals (inhibition) is disrupted, leading to seizures during sleep ^[10][11].

2. The “Growth Controllers” (GATOR1 Pathway)

A newer and very important group of genes belongs to the GATOR1 complex, which includes DEPDC5, NPRL2, and NPRL3 ^[2]. These genes normally act like a brake system for cell growth. If the brake fails, it can lead to focal cortical dysplasia (FCD)—a small area where brain cells didn’t form correctly ^[2][6].

• Hidden Lesions: In a specific surgical cohort, a subset of patients with DEPDC5 variants had FCD, though these can be so small they are invisible on a standard MRI. A germline GATOR1 variant does not mean that every carrier has a visible FCD ^[6][12].
• Drug Resistance: Seizures related to these genes can sometimes be harder to control with standard medications ^[2][13].

3. The “Channel Master” (KCNT1)

The KCNT1 gene controls a potassium channel in the brain. Depending on the variant, mutations here can sometimes be associated with a more severe phenotype ^[14].

• Severity: KCNT1 variants are sometimes associated with more frequent seizures and a higher risk of intellectual or behavioral challenges ^[15].
• Variable Outcomes: Even within the same family, one person with a KCNT1 variant might have mild nighttime seizures while another has a more severe form of epilepsy ^[16][17].

Should You Pursue Genetic Testing?

Genetic testing, through a specialized epilepsy gene panel, can sometimes help confirm the etiology (cause) of the epilepsy and guide inheritance counseling ^[18][19]. However, it rarely predicts exactly which medications will work. A test may return a negative result or a “variant of uncertain significance.”

(Note: Certain experimental treatments, such as nicotine patches or quinidine, have been studied in very specific genetic subsets. However, these are NOT routine treatments, have limited evidence, and can cause serious toxicity, including cardiac arrhythmias with quinidine. They must never be tried outside of formal, specialist supervision.)

Because of the privacy, insurance, and emotional considerations involved, genetic testing is best pursued in consultation with a genetic counselor who can help you interpret the results.